Conversion from twice-daily everolimus to once-daily sirolimus in long-term stable liver transplant recipients

CONCLUSION: The results of our study indicate that conversion from once-daily EVR to once-daily SIR in stable LT patients is safe, but needs dose adaptations and careful monitoring.PMID:38395088 | DOI:10.1016/j.trim.2024.102014

Source: Transplant Immunology - February 23, 2024 Category: Transplant Surgery Authors: J érôme Dumortier Olivier Boillot Source Type: research